Hansa Medical AB
Records under this name other than patents Hansa Medical AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,784,741 | Diagnostic method Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,133,483 | Method of treating or preventing a disease or condition mediated by pathogenic IgG antibodies Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,518,648 | Diagnostic method Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,889,128 | Use of the endoglycosidase endos for treating immunoglobulin G mediated diseases Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,126,312 | Diagnostic method for urinary tract infection Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,707,279 | Treatment for IgE-mediated disease Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,759,720 | Diagnostic method for bacterial meningitis Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,973,889 | Method for improving the benefit of organ transplant Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,696,959 | Cysteine Protease Formerly held In force · High confidence | In force | High confidence | |
| US 10,758,597 | Variant Cysteine Proteases Formerly held In force · High confidence | In force | High confidence |